2018 JDRF Financials in Three Charts
February 14, 2019
JDRF released their 2018 audited financial statements this week. Key takeaways are detailed in the bullets below.
Income grew by 9%, from $207 million in 2017 to $227 million, a solid gain. See Appendix A.
Total research grant funding in 2018 was $85 million, nearly half of the $156 million spent on research 10 years ago in 2008. See Appendix C.
The percent of income used for research grant funding was 37%, tying 2015 for the all-time organizational low. See Appendix B.
The lower levels of research grant spending directly correspond to the tenure and leadership direction of the current CEO, who started at the beginning of the 2015 fiscal year.
Nine out of ten donors say they want their donations to be used specifically for cure research, according to annual surveys. Yet, only a small percentage is actually attributed to research grants.
Last year, 205,000 people signed the JDCA 4th Annual More for a T1D Cure Petition asking JDRF, the ADA, and other major T1D non-profits to significantly increase research spending levels. JDRF has not publicly commented to date.
In the weeks ahead the JDCA will publish additional reports analyzing administration costs, JDRF mission alignment, and revenue/ expenses.
Appendix A: JDRF Total Annual Revenue
Appendix B: Research Grants as Percent of Total Revenue
Appendix C: JDRF Annual Research Grant Spending